Beyondspring Stock Today
| BYSI Stock | USD 1.42 0.07 4.70% |
PerformanceWeakest
| Odds Of DistressLow
|
BeyondSpring is trading at 1.42 as of the 12th of February 2026. This is a 4.7 percent decrease since the beginning of the trading day. The stock's open price was 1.49. BeyondSpring has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 14th of November 2025 and ending today, the 12th of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 9th of March 2017 | Category Healthcare | Classification Health Care |
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company was founded in 2010 and is headquartered in New York, New York. Beyondspring operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 40.33 M outstanding shares of which 2.4 M shares are currently shorted by private and institutional investors with about 43.7 trading days to cover. More on BeyondSpring
Moving together with BeyondSpring Stock
Moving against BeyondSpring Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
BeyondSpring Stock Highlights
| Thematic Idea | Cancer Fighters (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsDebt leverage enables BeyondSpring to amplify potential investment gains using borrowed funds. Evaluating debt relative to total assets helps investors assess BeyondSpring's financial structure and understand the extent to which BeyondSpring's operations depend on creditor capital.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BeyondSpring (BYSI) is traded on NASDAQ Exchange in USA and employs 40 people. BeyondSpring is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 83.08 M. BeyondSpring conducts business under Biotechnology sector and is part of Health Care industry. The entity has 40.33 M outstanding shares of which 2.4 M shares are currently shorted by private and institutional investors with about 43.7 trading days to cover.
BeyondSpring currently holds about 72.37 M in cash with (16.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check BeyondSpring Probability Of Bankruptcy
Ownership AllocationBeyondSpring holds a total of 40.33 Million outstanding shares. BeyondSpring shows 15.26 percent of its outstanding shares held by insiders and 14.34 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BeyondSpring Ownership Details
BeyondSpring Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Steward Partners Investment Advisory, Llc | 2025-06-30 | 1.1 K | |
| Tower Research Capital Llc | 2025-06-30 | 253 | |
| Jpmorgan Chase & Co | 2025-06-30 | 143 | |
| Sbi Securities Co Ltd | 2025-06-30 | 87.0 | |
| Bnp Paribas Arbitrage, Sa | 2025-06-30 | 9.0 | |
| Barclays Plc | 2025-03-31 | 4.0 | |
| Wells Fargo & Co | 2025-03-31 | 0.0 | |
| Banque Transatlantique | 2025-06-30 | 0.0 | |
| Citadel Advisors Llc | 2025-06-30 | 0.0 | |
| Decheng Capital Llc | 2025-06-30 | 4.5 M | |
| Blackrock Inc | 2025-06-30 | 635.1 K |
BeyondSpring Historical Income Statement
BeyondSpring Stock Against Markets
BeyondSpring Corporate Management
| Joy Jia | VP Finance | Profile | |
| Kenneth Lloyd | Chief Officer | Profile | |
| Gregg Russo | Senior Resources | Profile | |
| John Mao | Senior Development | Profile | |
| Stephen Kilmer | Head Relations | Profile | |
| June Lu | Chief Officer | Profile | |
| Linqing Jia | CoFounder | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeyondSpring. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. For more detail on how to invest in BeyondSpring Stock please use our How to Invest in BeyondSpring guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is there potential for Biotechnology market expansion? Will BeyondSpring introduce new products? Factors like these will boost the valuation of BeyondSpring. Projected growth potential of BeyondSpring fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about BeyondSpring listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.20) | Revenue Per Share | Quarterly Revenue Growth 0.143 | Return On Assets | Return On Equity |
Investors evaluate BeyondSpring using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating BeyondSpring's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause BeyondSpring's market price to deviate significantly from intrinsic value.
It's important to distinguish between BeyondSpring's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BeyondSpring should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BeyondSpring's market price signifies the transaction level at which participants voluntarily complete trades.